» Articles » PMID: 39521940

Exploring the CeRNA Network Involving AGAP2-AS1 As a Novel Biomarker for Preeclampsia

Overview
Journal Sci Rep
Specialty Science
Date 2024 Nov 9
PMID 39521940
Authors
Affiliations
Soon will be listed here.
Abstract

Preeclampsia (PE) is an important research subject in obstetrics. Nevertheless, the underlying mechanisms of PE remain elusive. PE-related expression datasets (GSE96983, GSE96984 and GSE24129) were downloaded from the Gene Expression Omnibus (GEO) database. Firstly, the differentially expressed messenger RNAs (DE-mRNAs), DE-microRNA (DE-miRNAs) and DE-long non-coding RNA (DE-lncRNAs) between PE and control cohorts were identified, and the ceRNA network was constructed. Then candidate hub genes were obtained through five algorithms by the protein-protein intersection (PPI) network of the mRNAs. Further, five hub genes were identified by receiver operating characteristic (ROC) curve and gene expression profiles: DAXX, EFNB1, NCOR2, RBBP4 and SOCS1. The function of 5 hub genes was analyzed and the interaction between drugs and hub genes was predicted. A total of 5 small molecule drugs were predicted, namely benzbromarone, 9,10-phenanthrenequinone, chembl312032, insulin and aldesleukin. AGAP2-AS1 was mainly located in exosome and cytoplasm. Agap2-as1-related regulatory subnetworks were extracted from ceRNA networks which included 41 mRNAs, 2 miRNAs and 1 lncRNA, including the regulated relationship pairs AGAP2-AS1-hsa-miR-497-5p-SRPRB, and AGAP2-AS1-hsa-miR-195-5p-RPL36. In summary, we constructed a competitive endogenous RNA (ceRNA) network to identify five potential biomarkers (DAXX, EFNB1, NCOR2, SOCS1 and RBBP4) of PE. The in-depth analysis of the AGAP2-AS1 regulatory network will help to uncover more important molecules closely related to PE and provide a scientific Reference.

References
1.
Gustavsson E, Zhang D, Reynolds R, Garcia-Ruiz S, Ryten M . ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics. 2022; 38(15):3844-3846. PMC: 9344834. DOI: 10.1093/bioinformatics/btac409. View

2.
Nishizawa H, Ota S, Suzuki M, Kato T, Sekiya T, Kurahashi H . Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol. 2011; 9:107. PMC: 3199758. DOI: 10.1186/1477-7827-9-107. View

3.
Xu Y, Wu D, Hui B, Shu L, Tang X, Wang C . A novel regulatory mechanism network mediated by lncRNA TUG1 that induces the impairment of spiral artery remodeling in preeclampsia. Mol Ther. 2022; 30(4):1692-1705. PMC: 9077368. DOI: 10.1016/j.ymthe.2022.01.043. View

4.
Sirico A, Rossi E, Degennaro V, Arena V, Rizzi A, Tartaglione L . Placental diabesity: placental VEGF and CD31 expression according to pregestational BMI and gestational weight gain in women with gestational diabetes. Arch Gynecol Obstet. 2022; 307(6):1823-1831. DOI: 10.1007/s00404-022-06673-3. View

5.
Lv Y, Lu C, Ji X, Miao Z, Long W, Ding H . Roles of microRNAs in preeclampsia. J Cell Physiol. 2018; 234(2):1052-1061. DOI: 10.1002/jcp.27291. View